TABLE 1

Baseline characteristics and pulmonary physiology

TOTALCTD-ILDNon-CTD-ILDCTD-ILD versus non-CTD-ILD
p-value#
IPAFIIP
Subjects n96272742
Age years66.4±10.361.5±8.964.2±11.171.0±8.80.003
Female n (%)43 (44.8)20 (74.1)15 (55.6)8 (19.0)<0.001
Smoking ever n (%)55 (57.3)10 (37.0)16 (59.3)29 (69.1)0.021
Caucasian n (%)79 (82.3)19 (70.4)23 (85.2)37 (88.1)0.075
Disease duration years7.4±7.711.3±10.64.3±3.06.9±6.50.002
Respiratory symptoms years5.7±5.45.6±4.84.3±3.06.6±6.70.292
Physiology
SpO2 %96.6±2.597.9±2.496.7±2.395.8±2.40.003
 FVC %73.9±17.877.0±17.772.3±18.872.8±17.50.281
DLCO %54.8±16.660.7±19.854.8±16.250.9±13.60.028
  6 MWT distance metres446.5±126.1+463.0±88.6421.5±138.6ƒ453.1±137.3##0.479
  6 MWT SpO2 nadir %90.0±7.1+94.3±3.690.0±7.9ƒ87.6±7.2##0.001
Composite indices
 CPI43.1±12.838.9±14.246.2±10.446.2±10.40.044
 ILD-GAP score1.9±2.20±1.61.2±1.52.5±1.5<0.001

Data represented as mean±sd unless otherwise stated. CTD-ILD: connective tissue disease associated ILD; IPAF: interstitial pneumonia with autoimmune features; IIP: idiopathic interstitial pneumonia; SpO2: peripheral oxygen saturation; FVC %: percentage predicted forced vital capacity; DLCO %: percentage predicted diffusing capacity for carbon monoxide; 6MWT: 6-min walk test; CPI: composite physiological index; ILD-GAP ILD: gender–age–physiology index. #: p-value for CTD-ILD versus non-CTD-ILD; : n=22; +: n=82; §: n=60; ƒ: n=24; ##: n=36.